TSE.4540

Supplementary Materials

The Fiscal Year Ended March 31, 2023

May 9, 2023

TSUMURA & CO.

Consolidated Statements of Income ・・・・・

1

Investments, R&D expenses, etc. ・・・・・

1

Product sales

・・・・・

2

Growth rates of 129 prescription Kampo products ・・・・・

2

Consolidated Balance Sheets

・・・・・

3

Consolidated Statements of Cash Flows ・・・・・

3

Quarterly data

Consolidated Statements of Income ・・・・・

4

Consolidated Balance Sheets

・・・・・

4

Consolidated Statements of Cash Flows ・・・・・

5

Product sales

・・・・・

5

Consolidated Statements of Income

(Million yen)

FY 3/2022

FY 3/2023

Year-on-year

Plan

Vs.planned

Full-year forecast for FY 3/2024

Year-on-

Year-on-

Amount

% of sales

Amount

% of sales

Amount

%

Amount

% of sales

Amount

%

Amount

% of sales

year

year

(Amount)

(%)

Net sales

129,546

100.0%

140,043

100.0%

10,497

8.1%

138,500

100.0%

1,543

101.1%

Net sales

150,500

100.0%

10,456

7.5%

Domestic

119,567

92.3%

124,684

89.0%

5,116

4.3%

124,200

89.7%

484

100.4%

Domestic business

133,300

88.6%

8,601

6.9%

Overseas

9,978

7.7%

15,359

11.0%

5,380

53.9%

14,300

10.3%

1,059

107.4%

China business

17,200

11.4%

1,854

12.1%

Cost of sales

63,081

48.7%

71,762

51.2%

8,680

13.8%

69,800

50.4%

1,962

102.8%

Cost of sales

83,000

55.1%

11,237

15.7%

Gross profit on sales

66,465

51.3%

68,281

48.8%

1,816

2.7%

68,700

49.6%

(418)

99.4%

Gross profit on sales

67,500

44.9%

(781)

(1.1)%

Selling, general and

44,088

34.0%

47,365

33.8%

3,277

7.4%

47,900

34.6%

(534)

98.9%

Selling, general and

49,500

32.9%

2,134

4.5%

administrative expenses

administrative expenses

Operating profit

18,000

12.0%

(2,916)

(13.9)%

Operating profit

22,376

17.3%

20,916

14.9%

(1,460)

(6.5)%

20,800

15.0%

116

100.6%

Domestic business

18,400

ー

(2,790)

(13.2)%

China business

(400)

ー

(126)

ー

Ordinary profit

25,904

20.0%

23,453

16.7%

(2,451)

(9.5)%

21,200

15.3%

2,253

110.6%

Ordinary profit

18,600

12.4%

(4,853)

(20.7)%

Profit attributable to owners

18,836

14.5%

16,482

11.7%

(2,354)

(12.5)%

15,000

10.8%

1,482

109.9%

Profit attributable to owners

13,000

8.6%

(3,482)

(21.1)%

of parent

of parent

Investments, R&D expenses, etc.

(Million yen)

FY 3/2022

FY 3/2023

Year-on-year

Plan

Vs.planned

Full-year forecast for FY 3/2024

Year-on-

Year-on-

Amount

% of sales

Amount

% of sales

Amount

%

Amount

% of sales

Amount

%

Amount

% of sales

year

year

(Amount)

(%)

Investments

12,095

9.3%

14,679

10.5%

2,584

21.4%

22,000

15.9%

(7,320)

66.7%

Investments

33,500

22.3%

18,820

128.2%

Capital investments

11,456

8.8%

11,172

8.0%

(284)

(2.5)%

17,500

12.6%

(6,327)

63.8%

Capital investments

29,500

19.6%

18,327

164.0%

R&D expenses

7,313

5.6%

7,594

5.4%

281

3.8%

7,600

5.5%

(5)

99.9%

R&D expenses

8,500

5.6%

905

11.9%

Advertising expenses

1,104

0.9%

1,026

0.7%

(78)

(7.1)%

1,000

0.7%

26

102.6%

Advertising expenses

1,000

0.7%

(26)

(2.6)%

Depreciation

8,743

6.7%

10,101

7.2%

1,358

15.5%

9,800

7.1%

301

103.1%

Depreciation

10,200

6.8%

98

1.0%

Personnel expenses

32,902

25.4%

34,244

24.5%

1,342

4.1%

34,800

25.1%

(555)

98.4%

Personnel expenses

36,800

24.5%

2,555

7.5%

※From the current consolidated fiscal year, the "acquisition of property, plant and equipment" has been changed to "investment amount of property, plant and equipment and software, etc." and the comparative figures have been rearranged.

1

Product sales

(Million yen)

Year-on-

Year-on-

Rank

No.

処方名

FY 3/2022

FY 3/2023

year

year

(Amount)

(%)

1

☆

100

Daikenchuto

9,569

9,739

169

1.8%

2

G

41

Hochuekkito

7,232

7,727

494

6.8%

3

☆

54

Yokukansan

7,379

7,380

1

0.0%

4

☆

43

Rikkunshito

7,231

7,300

69

1.0%

5

G

17

Goreisan

5,298

6,208

910

17.2%

6

G

24

Kamishoyosan

4,833

5,050

217

4.5%

7

68

Shakuyakukanzoto

4,763

4,893

130

2.7%

8

☆

107

Goshajinkigan

3,509

3,421

(87)

(2.5)%

9

114

Saireito

3,264

3,277

12

0.4%

10

29

Bakumondoto

3,258

3,236

(21)

(0.7)%

17

G

108

Ningin'yoeito

1,936

2,128

191

9.9%

18

G

137

Kamikihito

1,722

2,067

344

20.0%

24

☆

14

Hangeshashinto

1,358

1,390

32

2.4%

Total of "Drug Fostering" Program formulations

29,048

29,233

184

0.6%

Total of Growing formulations

21,023

23,182

2,159

10.3%

Total of 129 prescription Kampo products

114,165

119,362

5,197

4.6%

☆

："Drug Fostering" Program formulations

  1. ：Growing formulations

Growth rates of 129 prescription Kampo products

FY 3/2023

FY 3/2023

FY 3/2023

FY 3/2023

FY 3/2019

FY 3/2020

FY 3/2021

FY 3/2022

2Q

3Q

4Q

1Q

cumulative

cumulative

cumulative

Amount

2.7%

1.8%

1.1%

8.1%

6.7%

6.8%

5.3%

4.6%

Number of items with higher yen sales

83

66

82

110

101

106

99

98

2

Consolidated Balance Sheets

(Million yen)

As of March 31,

As of

March 31,

Increase /

2022

2023

decrease

Total assets

350,981

396,813

45,831

Current assets

229,420

268,320

38,900

Liquid assets

122,431

152,839

30,408

Inventories

92,751

101,726

8,974

Non-current assets

121,561

128,492

6,931

Property, plant and equipment

90,040

93,415

3,375

Total liabilities

92,871

124,566

31,695

Current liabilities

45,875

47,205

1,329

Non-current liabilities

46,996

77,361

30,365

Total net assets

258,109

272,246

14,136

Consolidated Statements of Cash Flows

(Million yen)

As of March 31,

As of

March 31,

Increase /

2022

2023

decrease

Cash flows from operating activities

21,314

16,452

(4,861)

Cash flows from investing activities

(9,111)

(15,493)

(6,382)

Cash flows from financing activities

(8,181)

24,423

32,604

Cash and cash equivalents at the end of the quarter

67,536

94,730

27,194

3

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Tsumura & Co. published this content on 09 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 May 2023 07:39:05 UTC.